We randomly assigned @ patients undergoing coronary stent follow-up with the use of MDCT-CA to iomeprol-@ at @ mL/sec flow rate ( group @ ; n = @ ) , iodixanol-@ at @ mL/sec flow rate ( group @ ; n = @ ) , and iodixanol-@ at @ mL/sec flow rate ( group @ ; n = @ ) .